Last updated on July 2019

Study the Efficacy and Safety of VAY736 and CFZ533 in SLE Patients


Brief description of study

This study is designed to evaluate the safety, tolerability, pharmacokinetics and therapeutic efficacy of treatment with either VAY736 or CFZ533 in patients with SLE to enable further development of these compounds as treatment in this disease population

Clinical Study Identifier: NCT03656562

Find a site near you

Start Over

Novartis Investigative Site

Ciudad Autonoma de Bs As, Argentina
  Connect »

Novartis Investigative Site

Suwon si, Korea, Republic of
  Connect »

Novartis Investigative Site

Gwangju, Korea, Republic of
  Connect »

Novartis Investigative Site

St Petersburg, Russian Federation
  Connect »

Novartis Investigative Site

Ekaterinburg, Russian Federation
  Connect »

Novartis Investigative Site

Saint-Petersburg, Russian Federation
  Connect »